<tbody id="grid1_body_tbody"><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_0_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="0" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_0_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="1" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성화재해상보험(000810)</nobr></td><td datatype="" displayformat="" id="grid1_cell_0_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="2" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>SamsungF&amp;MIns-3Q review: Becoming more competitive<br>ㅁ Investment profit down due to seasonality and one-off costs<br>ㅁ New business CSM growth a positive development<br>ㅁ Maintaining BUY</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_0_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="3" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="4" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>310,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_0_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="5" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>249,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_0_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="6" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_0_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="7" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정민기</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_1_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="8" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_1_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="9" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성화재해상보험(000810)</nobr></td><td datatype="" displayformat="" id="grid1_cell_1_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="10" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성화재-3Q review: 본질적 경쟁력 강화가 이어지는 중<br>ㅁ 보험손익 계절성 및 일회성 투자 비용 발생<br>ㅁ 신계약 CSM 성장 확대 긍정적</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_1_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="11" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="12" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>310,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_1_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="13" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>249,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_1_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="14" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_1_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="15" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정민기</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_2_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="16" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_2_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="17" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>씨제이(001040)</nobr></td><td datatype="" displayformat="" id="grid1_cell_2_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="18" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>CJ-올리브영 순항 중. 과징금 관련 시장 우려도 다소 과도<br>ㅁ 한한령 해제에 따른 입국자 수 급증은 없었지만 올리브영의 성장성은 여전히 견고<br>ㅁ 올리브영의 독점거래 강요 관련 과징금에 대한 시장 우려도 다소 과도하다고 판단</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_2_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="19" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="20" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>120,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_2_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="21" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>89,000</nobr></td><td datatype="text" displayformat="" id="grid1_cell_2_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="22" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_2_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="23" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>최정욱.김현수</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_3_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="24" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_3_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="25" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>디비손해보험(005830)</nobr></td><td datatype="" displayformat="" id="grid1_cell_3_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="26" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>DB Insurance-3Q review: Fundamentals remain intact<br>ㅁ 3Q results sluggish due to one-off costs at commercial lines and revaluation loss on invested assets<br>ㅁ Implications from adoption of FSS’ actuarial assumption guideline</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_3_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="27" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="28" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>96,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_3_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="29" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>82,100</nobr></td><td datatype="text" displayformat="" id="grid1_cell_3_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="30" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_3_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="31" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정민기</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_4_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="32" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_4_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="33" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>디비손해보험(005830)</nobr></td><td datatype="" displayformat="" id="grid1_cell_4_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="34" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>DB손해보험-3Q review: 펀더멘털 이상 무<br>ㅁ 일반보험 및 투자 부문 일회성 요인으로 부진<br>ㅁ 계리적 가이드라인 관련 영향</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_4_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="35" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="36" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>96,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_4_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="37" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>82,100</nobr></td><td datatype="text" displayformat="" id="grid1_cell_4_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="38" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_4_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="39" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정민기</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_5_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="40" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_5_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="41" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>롯데칠성음료(005300)</nobr></td><td datatype="" displayformat="" id="grid1_cell_5_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="42" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>롯데칠성-KRUSH 출시<br>ㅁ 수익성 방어 능력 충분<br>ㅁ 맥주 신제품 기대감 확대 전망<br>ㅁ 투자의견 BUY, 목표주가 210,000원</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_5_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="43" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="44" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>210,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_5_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="45" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>156,400</nobr></td><td datatype="text" displayformat="" id="grid1_cell_5_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="46" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>키움증권</nobr></td><td id="grid1_cell_5_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="47" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박상준.신대현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_6_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="48" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/16</nobr></td><td datatype="text" id="grid1_cell_6_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="49" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>코리안리재보험(003690)</nobr></td><td datatype="" displayformat="" id="grid1_cell_6_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="50" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>코리안리-힘을 숨기는 중<br>ㅁ 3Q23 별도 순이익 240억원(-50% YoY), 어닝 쇼크 실질의 개선 지속<br>ㅁ ‘실질’의 개선 지속<br>ㅁ IFRS4 기준 배당성향 30% 가정 시, 기대 DY 7.7%</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_6_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="51" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="52" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>12,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_6_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="53" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>8,620</nobr></td><td datatype="text" displayformat="" id="grid1_cell_6_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="54" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한화투자증권</nobr></td><td id="grid1_cell_6_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="55" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김도하</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_7_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="56" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_7_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="57" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대한항공(003490)</nobr></td><td datatype="" displayformat="" id="grid1_cell_7_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="58" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대한항공-3Q Review: 여행의 민족<br>ㅁ 3분기 영업이익 컨센서스 부합 <br>ㅁ 비싸도 여행은 못 참지 <br>ㅁ 실적 향상 업사이드 유효</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_7_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="59" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="60" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>32,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_7_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="61" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>21,950</nobr></td><td datatype="text" displayformat="" id="grid1_cell_7_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="62" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신한투자증권</nobr></td><td id="grid1_cell_7_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="63" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>명지운</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_8_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="64" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_8_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="65" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>YG엔터테인먼트(122870)</nobr></td><td datatype="" displayformat="" id="grid1_cell_8_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="66" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>와이지엔터테인먼트-역대급 팬덤 낙수효과 기대<br>ㅁ 블랙핑크 멤버 2명 이상 재계약 시 즉시 목표주가 상향 계획<br>ㅁ 베몬 팬덤 낙수효과에 용이한 환경. 상당 수준의 초기 팬덤 형성 예상<br>ㅁ 트레져의 성장과 베몬의 유의미한 이익기여로 매출 하락 방어 가능</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_8_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="67" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="68" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>80,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_8_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="69" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>59,800</nobr></td><td datatype="text" displayformat="" id="grid1_cell_8_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="70" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>대신증권</nobr></td><td id="grid1_cell_8_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="71" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>임수진</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_9_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="72" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_9_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="73" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>두산테스나(131970)</nobr></td><td datatype="" displayformat="" id="grid1_cell_9_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="74" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>두산테스나-24년에도 모바일 외 성장 지속<br>ㅁ 3분기 영업이익 174억원(-4% QoQ) 기록 <br>ㅁ 4분기 영업이익 197억원(+13% QoQ) 전망 <br>ㅁ 2024년 스마트폰 회복 및 모바일 외 비중 확대 <br>ㅁ 2019년 이후 여전히 성장 중인 OSAT 업체</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_9_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="75" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="76" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>65,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_9_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="77" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>54,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_9_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="78" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>신한투자증권</nobr></td><td id="grid1_cell_9_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="79" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>남궁현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_10_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="80" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_10_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="81" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>두산테스나(131970)</nobr></td><td datatype="" displayformat="" id="grid1_cell_10_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="82" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>DOOSAN TESNA-Non-mobile growth to continue into 2024<br>ㅁ 3Q23 operating profit comes in at KRW17.4bn (-4% QoQ)<br>ㅁ 4Q23 operating profit forecast at KRW19.7bn (+13% QoQ)<br>ㅁ 2024 outlook: Improving smartphone demand &amp; rising non-mobile sales</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_10_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="83" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="84" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>65,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_10_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="85" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>54,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_10_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="86" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Shinhan Investment &amp;</nobr></td><td id="grid1_cell_10_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="87" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>남궁현</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_11_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="88" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_11_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="89" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>두산테스나(131970)</nobr></td><td datatype="" displayformat="" id="grid1_cell_11_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="90" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>두산테스나-역시나 안정적인 실적<br>ㅁ 2023년 3분기 잠정 매출액은 892억원(YoY +30.7%, QoQ+0.3%), 영업이익은 174억원(YoY +3.7%, QoQ -4.1%)을 시현<br>ㅁ 4분기 가동률은 CIS가 80% 수준까지 상승할 것으로 보이며, SoC 가동률은 60% 초반으로 소폭 하락할 것으로 보임</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_11_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="91" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="92" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>70,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_11_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="93" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>54,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_11_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="94" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>현대차증권</nobr></td><td id="grid1_cell_11_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="95" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박준영</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_12_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="96" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_12_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="97" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈(166090)</nobr></td><td datatype="" displayformat="" id="grid1_cell_12_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="98" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈-가까워지는 방향 전환<br>ㅁ 3분기 실적은 부진했으나, 4분기를 기점으로 이익의 방향성은 전환될 것으로 예상.<br>ㅁ 주력 고객사의 NAND Etcher 점유율 확대 효과와 평택, 시안 등으로의 SiC 링 저변 확대 효과가 내년부터 서서히 나타나기 시작할 것으로 전망.<br>ㅁ 2024년 이익 하향 분을 감안하여 목표주가는 63,000원으로 하향하나, 매수의견 유지. 다가올 가동률의 반등 사이클에서 기대 가능한 Upside가 크다는 판단.</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_12_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="99" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="100" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_12_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="101" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>49,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_12_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="102" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_12_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="103" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>류형근</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_13_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="104" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_13_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="105" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈(166090)</nobr></td><td datatype="" displayformat="" id="grid1_cell_13_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="106" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Hana Materials-Turnaround drawing closer<br>ㅁ Hana Materials posted sluggish 3Q earnings, but should see a turnaround in earnings after bottoming out in 4Q<br>ㅁ We believe the firm will benefit from: 1) its key client expanding its share in the NAND etcher market; and 2) the adoption of SiC rings expanding into the Pyeongtaek and Xian fabs.<br>ㅁ We cut our target price for the firm to KRW63,000 to reflect our 2024 earnings estimate cut. Still, we keep the stock at BUY, expecting great upside in an upcoming rebound in semiconductor utilization rates.</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_13_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="107" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="108" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_13_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="109" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>49,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_13_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="110" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_13_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="111" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>류형근</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_14_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="112" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_14_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="113" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈(166090)</nobr></td><td datatype="" displayformat="" id="grid1_cell_14_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="114" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나머티리얼즈-길게 볼수록 좋다<br>ㅁ 3Q23 실적 예상치 하회<br>ㅁ 2024년 실적의 회복세는 높지 않을 것<br>ㅁ 투자의견 Buy, 목표주가 63,000원 유지</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_14_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="115" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="116" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_14_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="117" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>49,600</nobr></td><td datatype="text" displayformat="" id="grid1_cell_14_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="118" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이베스트투자증권</nobr></td><td id="grid1_cell_14_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="119" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>차용호</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_15_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="120" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_15_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="121" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>엔에이치엔(181710)</nobr></td><td datatype="" displayformat="" id="grid1_cell_15_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="122" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>NHN-기대할 것이 많은 한 해<br>ㅁ 목표주가 29,000 원으로 커버리지 개시<br>ㅁ 24 년도 영업이익 1,160 억원 예상<br>ㅁ 한국 클라우드 시장 본격 개화</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_15_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="123" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="124" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>29,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_15_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="125" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>23,350</nobr></td><td datatype="text" displayformat="" id="grid1_cell_15_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="126" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하이투자증권</nobr></td><td id="grid1_cell_15_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="127" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>윤예지</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_16_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="128" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_16_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="129" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>코미코(183300)</nobr></td><td datatype="" displayformat="" id="grid1_cell_16_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="130" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>코미코-디램 노출도 높은 편안한 선택지<br>ㅁ 목표주가 63,000원으로 커버리지 개시<br>ㅁ 높은 디램 노출도에 기인한 실적 개선 가시성 주목<br>ㅁ 자회사 미코세라믹스 편입 시너지 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_16_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="131" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="132" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>63,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_16_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="133" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>52,300</nobr></td><td datatype="text" displayformat="" id="grid1_cell_16_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="134" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>한화투자증권</nobr></td><td id="grid1_cell_16_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="135" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김광진.최영주</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_17_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="136" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_17_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="137" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서연이화(200880)</nobr></td><td datatype="" displayformat="" id="grid1_cell_17_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="138" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>서연이화-3분기 수익성 다시 상승<br>ㅁ 3Q23 Review: 영업이익률 6.3% 기록<br>ㅁ 최근 2년 간 매출액이 65% 성장<br>ㅁ P/E 2배 대에서 거래 중</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_17_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="139" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="140" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_17_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="141" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>16,810</nobr></td><td datatype="text" displayformat="" id="grid1_cell_17_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="142" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하나증권</nobr></td><td id="grid1_cell_17_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="143" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>송선재.안도현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_18_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="144" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_18_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="145" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이치엘만도(204320)</nobr></td><td datatype="" displayformat="" id="grid1_cell_18_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="146" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HL만도-“지금 어느 동아줄을 붙잡고 있는가”라고 물을 때 돋보이는 부품사<br>ㅁ 북미 전기차 선도 업체에 대한 EPB (전자파킹브레이크), EPS (파워스티어링) 공급 중. IDB2 공급 예정<br>ㅁ Rivian 등 북미 전기차 스타트업들에도 ADAS 시스템, 센서 등을 공급<br>ㅁ 중국 자동차 내수 시장의 회복으로부터 수혜 가능</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_18_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="147" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="148" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>52,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_18_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="149" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>34,950</nobr></td><td datatype="text" displayformat="" id="grid1_cell_18_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="150" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>KB증권</nobr></td><td id="grid1_cell_18_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="151" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>강성진</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_19_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="152" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_19_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="153" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알테오젠(196170)</nobr></td><td datatype="" displayformat="" id="grid1_cell_19_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="154" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>알테오젠-바빠지고 있다<br>ㅁ 투자의견 BUY 및 목표주가 90,000원으로 상향: 마일스톤 유입으로 인한 이익 창출력을 선반영(도표 1 참고)<br>ㅁ 2024년 초부터 면역항암제 SC제형들 출시 예정: 티센트릭®SC(로슈), 옵디보® SC (BMS) 임상 3상 성공으로<br>ㅁ 2차 계약사와 SC제형 특허권 이전, 2차 CMO 선정 및 확정 등과 관련된 논의가 진행되고 있을 것으로 추정</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_19_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="155" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="156" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>90,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_19_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="157" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>72,300</nobr></td><td datatype="text" displayformat="" id="grid1_cell_19_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="158" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_19_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="159" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>권해순</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_20_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="160" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_20_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="161" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>제이앤티씨(204270)</nobr></td><td datatype="" displayformat="" id="grid1_cell_20_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="162" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>제이앤티씨-3Q23 Review: 중국 화웨이향 강화유리, 4분기에도 공급 확대 수혜 기대<br>ㅁ 3Q23 Review: 매출액은 전년동기 대비 168.5% 증가. 영업이익은 전분기에 이어 흑자전환 성공<br>ㅁ 4Q23 Preview: 14분기만에 분기 매출액이 1,000억원대를 돌파하는 것도 긍정적임</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_20_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="163" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Not Rated</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="164" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr></nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_20_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="165" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>13,790</nobr></td><td datatype="text" displayformat="" id="grid1_cell_20_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="166" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_20_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="167" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종선</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_21_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="168" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_21_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="169" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_21_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="170" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-우려를 이겨내는 실적<br>ㅁ 3Q23 review: 의료기기 내수 성장 및 화장품 수출 성장, 홈쇼핑 채널 축소를 통한 판관비 감소로 영업이익 컨센서스 상회.<br>ㅁ 투자의견 BUY, 목표주가 19만원 유지: 리쥬란 브랜드 확장 지속 중이며, 출시 초기국가 중심 매출 상승 기대. 콘쥬란 급여 기준 강화 이슈는 지속 확인 필요.</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_21_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="171" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="172" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>190,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_21_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="173" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_21_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="174" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_21_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="175" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동희</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_22_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="176" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_22_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="177" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_22_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="178" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>PharmaResearch-Steady sales growth of medical devices and cosmetics<br>ㅁ 3Q review<br>ㅁ Maintaining BUY and KRW190,000 target</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_22_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="179" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="180" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>190,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_22_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="181" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_22_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="182" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>삼성증권</nobr></td><td id="grid1_cell_22_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="183" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>정동희</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_23_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="184" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_23_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="185" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_23_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="186" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-또 역대급 실적, 성장판 많이 열려있다<br>ㅁ 3Q23 매출액 및 영업이익 당사 추정치/컨센서스 상회<br>ㅁ 동사의 성장 동력인 화장품과 의료기기 성장 지속 가능 판단<br>ㅁ 글로벌 국가 확대 및 화장품 신제품 출시 통해 매출 확대 기대</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_23_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="187" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="188" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>180,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_23_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="189" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_23_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="190" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>다올투자증권</nobr></td><td id="grid1_cell_23_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="191" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종현.이정우</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_24_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="192" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_24_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="193" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_24_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="194" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-3Q23 Review: 기대치를 상회하는 영업현황 확인<br>ㅁ 3Q23 Review: 매출액 688억원(+49% yoy), 영업이익 275억원(+66% yoy)<br>ㅁ 수출 국가 확대를 통한 성장에 관심이 높아지는 시점</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_24_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="195" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="196" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>175,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_24_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="197" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_24_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="198" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>이베스트투자증권</nobr></td><td id="grid1_cell_24_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="199" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>조은애</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_25_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="200" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_25_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="201" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치(214450)</nobr></td><td datatype="" displayformat="" id="grid1_cell_25_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="202" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>파마리서치-리쥬란브랜드 파워 실적으로 확인<br>ㅁ 3분기 어닝 서프라이즈 실현<br>ㅁ 리쥬란 스킨부스터, 리쥬란 화장품 브랜드 잠재력에 주목한다<br>ㅁ 4분기 영업실적 전망도 긍정적</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_25_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="203" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="204" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>180,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_25_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="205" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>115,900</nobr></td><td datatype="text" displayformat="" id="grid1_cell_25_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="206" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>상상인증권</nobr></td><td id="grid1_cell_25_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="207" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>하태기</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_26_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="208" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_26_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="209" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이제이네트웍스(095570)</nobr></td><td datatype="" displayformat="" id="grid1_cell_26_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="210" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>AJ네트웍스-3Q23 Review: 매출 부진에도 불구하고,수익성 개선은 긍정적.<br>ㅁ 3Q23 Review: 매출액은 감소세를 보이나, 수익성은 개선되어 영업이익은 시장 기대치를 상회<br>ㅁ 4Q23 Preview: 전년 동기 수준의 매출액을 예상하지만, 수익성 개선은 지속될 것으로 전망</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_26_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="211" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="212" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>6,500</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_26_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="213" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>4,095</nobr></td><td datatype="text" displayformat="" id="grid1_cell_26_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="214" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_26_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="215" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>박종선</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_27_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="216" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_27_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="217" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>레이(228670)</nobr></td><td datatype="" displayformat="" id="grid1_cell_27_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="218" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>레이-예상되었던 부진, 4Q23 실적의 핵심은 미국 시장<br>ㅁ 매출 및 영업이익 모두 시장기대치 하회하는 실적 달성<br>ㅁ 현 주가는 12개월 선행 P/E 16배로 동사의 지난 1년 평균(33배) 및 글로벌 Peer(24배) 대비 저평가</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_27_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="219" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="220" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>32,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_27_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="221" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>20,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_27_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="222" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>미래에셋증권</nobr></td><td id="grid1_cell_27_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="223" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김충현</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_28_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="224" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_28_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="225" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>레이(228670)</nobr></td><td datatype="" displayformat="" id="grid1_cell_28_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="226" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Ray-Sluggish 3Q23 results; US market to hold the key in 4Q23<br>ㅁ Revenue and OP miss consensus<br>ㅁ Undervalued at a 12-month forward P/E of 16x vs. one-year average of 33x and global peer average of 24x</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_28_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="227" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>매수</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="228" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>32,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_28_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="229" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>20,500</nobr></td><td datatype="text" displayformat="" id="grid1_cell_28_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="230" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>Mirae Asset Securiti</nobr></td><td id="grid1_cell_28_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="231" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>김충현</nobr></td></tr><tr id="row22" style="background-color: rgb(241, 247, 254);" role="row" trindex="0" class="grid_body_row"><td id="grid1_cell_29_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="232" or_wd="100" or_bgcolor="" style_bak="text-align:center;height:20px"><nobr>2023/11/15</nobr></td><td datatype="text" id="grid1_cell_29_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="233" or_wd="140" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>에이치케이이노엔(195940)</nobr></td><td datatype="" displayformat="" id="grid1_cell_29_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="234" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>HK이노엔-2024년에도 지속되는 성장 스토리<br>ㅁ 투자의견 BUY 및 목표주가 50,000원으로 신규 제시<br>ㅁ 2024년 주가 Catalysts: 케이캡® 국내 및 글로벌 판매 수익 증가, 미국 임상 완료<br>ㅁ Phathom Pharmaceuticals(NASDAQ: PHAT)의 보？자®(다케다 보노프라잔 미국 브랜드) FDA 승인(10월 30일)</nobr></td><td datatyp="text" displayformat="" id="grid1_cell_29_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="235" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>BUY</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="236" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>50,000</nobr></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_29_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="237" or_wd="80" or_bgcolor="" style_bak="text-align:right;height:20px"><nobr>42,050</nobr></td><td datatype="text" displayformat="" id="grid1_cell_29_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="238" or_wd="100" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>유진투자증권</nobr></td><td id="grid1_cell_29_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="239" or_wd="50" or_bgcolor="" style_bak="text-align:left;height:20px"><nobr>권해순</nobr></td></tr><tr id="row22" style="background-color: rgb(255, 255, 255); display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_30_0" style="text-align: center; height: 20px;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="240" or_wd="100" style_bak="text-align:center;height:20px" or_bgcolor=""></td><td datatype="text" id="grid1_cell_30_1" inputtype="text" style="text-align: left; height: 20px;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="241" or_wd="140" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="" displayformat="" id="grid1_cell_30_2" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="242" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatyp="text" displayformat="" id="grid1_cell_30_3" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="243" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_4" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="244" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_30_5" inputtype="text" style="text-align: right; height: 20px;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="245" or_wd="80" style_bak="text-align:right;height:20px" or_bgcolor=""></td><td datatype="text" displayformat="" id="grid1_cell_30_6" inputtype="text" style="text-align: left; height: 20px;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="246" or_wd="100" style_bak="text-align:left;height:20px" or_bgcolor=""></td><td id="grid1_cell_30_7" style="text-align: left; height: 20px;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="247" or_wd="50" style_bak="text-align:left;height:20px" or_bgcolor=""></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_31_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="248" or_wd="100"></td><td datatype="text" id="grid1_cell_31_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="249" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_31_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="250" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_31_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="251" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="252" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_31_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="253" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_31_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="254" or_wd="100"></td><td id="grid1_cell_31_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="255" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_32_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="256" or_wd="100"></td><td datatype="text" id="grid1_cell_32_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="257" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_32_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="258" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_32_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="259" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="260" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_32_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="261" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_32_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="262" or_wd="100"></td><td id="grid1_cell_32_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="263" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_33_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="264" or_wd="100"></td><td datatype="text" id="grid1_cell_33_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="265" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_33_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="266" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_33_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="267" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="268" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_33_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="269" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_33_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="270" or_wd="100"></td><td id="grid1_cell_33_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="271" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_34_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="272" or_wd="100"></td><td datatype="text" id="grid1_cell_34_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="273" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_34_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="274" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_34_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="275" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="276" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_34_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="277" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_34_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="278" or_wd="100"></td><td id="grid1_cell_34_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="279" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_35_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="280" or_wd="100"></td><td datatype="text" id="grid1_cell_35_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="281" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_35_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="282" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_35_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="283" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="284" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_35_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="285" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_35_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="286" or_wd="100"></td><td id="grid1_cell_35_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="287" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_36_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="288" or_wd="100"></td><td datatype="text" id="grid1_cell_36_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="289" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_36_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="290" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_36_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="291" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="292" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_36_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="293" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_36_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="294" or_wd="100"></td><td id="grid1_cell_36_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="295" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_37_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="296" or_wd="100"></td><td datatype="text" id="grid1_cell_37_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="297" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_37_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="298" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_37_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="299" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="300" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_37_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="301" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_37_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="302" or_wd="100"></td><td id="grid1_cell_37_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="303" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_38_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="304" or_wd="100"></td><td datatype="text" id="grid1_cell_38_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="305" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_38_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="306" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_38_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="307" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="308" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_38_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="309" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_38_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="310" or_wd="100"></td><td id="grid1_cell_38_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="311" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_39_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="312" or_wd="100"></td><td datatype="text" id="grid1_cell_39_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="313" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_39_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="314" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_39_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="315" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="316" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_39_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="317" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_39_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="318" or_wd="100"></td><td id="grid1_cell_39_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="319" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_40_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="320" or_wd="100"></td><td datatype="text" id="grid1_cell_40_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="321" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_40_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="322" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_40_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="323" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="324" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_40_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="325" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_40_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="326" or_wd="100"></td><td id="grid1_cell_40_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="327" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_41_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="328" or_wd="100"></td><td datatype="text" id="grid1_cell_41_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="329" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_41_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="330" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_41_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="331" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="332" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_41_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="333" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_41_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="334" or_wd="100"></td><td id="grid1_cell_41_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="335" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_42_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="336" or_wd="100"></td><td datatype="text" id="grid1_cell_42_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="337" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_42_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="338" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_42_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="339" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="340" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_42_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="341" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_42_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="342" or_wd="100"></td><td id="grid1_cell_42_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="343" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_43_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="344" or_wd="100"></td><td datatype="text" id="grid1_cell_43_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="345" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_43_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="346" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_43_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="347" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="348" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_43_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="349" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_43_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="350" or_wd="100"></td><td id="grid1_cell_43_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="351" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_44_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="352" or_wd="100"></td><td datatype="text" id="grid1_cell_44_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="353" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_44_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="354" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_44_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="355" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="356" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_44_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="357" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_44_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="358" or_wd="100"></td><td id="grid1_cell_44_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="359" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_45_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="360" or_wd="100"></td><td datatype="text" id="grid1_cell_45_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="361" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_45_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="362" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_45_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="363" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="364" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_45_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="365" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_45_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="366" or_wd="100"></td><td id="grid1_cell_45_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="367" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_46_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="368" or_wd="100"></td><td datatype="text" id="grid1_cell_46_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="369" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_46_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="370" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_46_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="371" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="372" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_46_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="373" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_46_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="374" or_wd="100"></td><td id="grid1_cell_46_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="375" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_47_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="376" or_wd="100"></td><td datatype="text" id="grid1_cell_47_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="377" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_47_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="378" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_47_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="379" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="380" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_47_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="381" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_47_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="382" or_wd="100"></td><td id="grid1_cell_47_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="383" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_48_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="384" or_wd="100"></td><td datatype="text" id="grid1_cell_48_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="385" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_48_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="386" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_48_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="387" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="388" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_48_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="389" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_48_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="390" or_wd="100"></td><td id="grid1_cell_48_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="391" or_wd="50"></td></tr><tr id="row22" style="display: none;" role="row" trindex="0" class="grid_body_row w2grid_hidedRow"><td id="grid1_cell_49_0" style="text-align: center;" displayformat="yyyy/MM/dd" inputtype="text" datatype="date" textalign="center" value="" colindex="0" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_0_" col_id="STD_DT" tdindex="392" or_wd="100"></td><td datatype="text" id="grid1_cell_49_1" inputtype="text" style="text-align: left;" textalign="left" displayformat="" value="" colindex="1" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_1_" col_id="REP_SECN" tdindex="393" or_wd="140"></td><td datatype="" displayformat="" id="grid1_cell_49_2" inputtype="text" style="text-align: left;" textalign="left" value="" displaytype="all" displayformatter="fn_Enter" colindex="2" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_2_" col_id="ENTR_SUMM_CONTENT" tdindex="394" or_wd="100"></td><td datatyp="text" displayformat="" id="grid1_cell_49_3" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="3" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_3_" col_id="INVST_OPINION_GRD_CONTENT" tdindex="395" or_wd="100"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_4" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="4" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_4_" col_id="TARGET_PRICE" tdindex="396" or_wd="80"></td><td datatype="number" displayformat="#,###.##" id="grid1_cell_49_5" inputtype="text" style="text-align: right;" textalign="right" value="" colindex="5" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_5_" col_id="CPRI" tdindex="397" or_wd="80"></td><td datatype="text" displayformat="" id="grid1_cell_49_6" inputtype="text" style="text-align: left;" textalign="left" value="" colindex="6" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_6_" col_id="WROT_ORG_NM" tdindex="398" or_wd="100"></td><td id="grid1_cell_49_7" style="text-align: left;" inputtype="text" textalign="left" datatype="text" value="" displayformat="" colindex="7" role="gridcell" class="gridBodyDefault gridBodyDefault_data grid1_columnstyle_7_" col_id="WRITER_NM" tdindex="399" or_wd="50"></td></tr></tbody>